Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion

@article{Hoeh2009LongtermFO,
  title={Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion},
  author={Alexandra Eva Hoeh and Thomas Ach and Karen Beate Schaal and Alexander Friedrich Scheuerle and Stefan Dithmar},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={2009},
  volume={247},
  pages={1635-1641}
}
To evaluate the long-term outcome of an OCT-guided reinjection scheme for bevacizumab treatment of macular edema (ME) due to retinal vein occlusion. Patients with persistent ME (>250 μm) due to central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) received intravitreal bevacizumab 2.5 mg/0.1 ml. Visual acuity (ETDRS), ophthalmic… CONTINUE READING